» Articles » PMID: 38104216

A Clinical Assessment of Portable Point-of-care Testing for Quick Cortisol Assay During Adrenal Vein Sampling

Abstract

This study assessed the clinical performance of point-of-care testing (POCT) for quick cortisol assay (QCA) during adrenal vein sampling (AVS) using a newly invented portable quantitative assay instrument. An observational study was conducted prospectively at two centres in Japan. Forty-eight patients with primary aldosteronism considered for adrenalectomy were enrolled in this study and underwent AVS. Three basal adrenal vein samples from each adrenal vein and two from the inferior vena cava were collected sequentially. The cortisol concentration of adrenal vein samples was measured by routine method and QCA. A total of 338 adrenal vein samples were analysed from 250 sites to determine AVS success or failure. The distribution of turnaround time of the QCA for AVS success or failure followed a normal distribution with an average of 20.5 min. A positive correlation between the routine method and QCA was observed regarding cortisol concentration or selectivity index. No significant difference between the two methods was observed regarding the success rate of AVS. Using the routine method as a reference, the sensitivity and specificity of AVS success or failure were 99.1% (210/212) and 81.6% (31/38), respectively. Easy, quick, portable, and precise POCT-QCA demonstrated its compatibility with routine methods regarding clinical performance.

Citing Articles

Artificial intelligence in managing retinal disease-current concepts and relevant aspects for health care providers.

Riedl S, Birner K, Schmidt-Erfurth U Wien Med Wochenschr. 2025; .

PMID: 39992600 DOI: 10.1007/s10354-024-01069-1.


Using Point of Care Rapid Cortisol Measurement During Adrenal Venous Sampling in Primary Hyperaldosteronism.

Rabani H, Sheikh-Ahmad M, Sachner R, Yosefia S, Yeiches M, Chen-Konak L Diagnostics (Basel). 2024; 14(23).

PMID: 39682600 PMC: 11640027. DOI: 10.3390/diagnostics14232692.

References
1.
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F . Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017; 69(14):1811-1820. DOI: 10.1016/j.jacc.2017.01.052. View

2.
Wu X, Yu J, Tian H . Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(26):e15985. PMC: 6617487. DOI: 10.1097/MD.0000000000015985. View

3.
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y . Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Hypertension. 2018; 71(3):530-537. DOI: 10.1161/HYPERTENSIONAHA.117.10263. View

4.
Funder J, Carey R, Mantero F, Murad M, Reincke M, Shibata H . The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5):1889-916. DOI: 10.1210/jc.2015-4061. View

5.
Turcu A, Auchus R . Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling. J Clin Endocrinol Metab. 2020; 106(4):1195-1208. PMC: 7993592. DOI: 10.1210/clinem/dgaa952. View